Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Neurobiological Signatures of Psychosis Across Dementia Subtypes

EF 2025-26

Résumé
Dementia-related psychosis (DRP), which includes hallucinations and delusions, affects up to one-third of individuals with dementia and is associated with accelerated cognitive decline, earlier placement in care facilities, and substantial caregiver burden. DRP varies across dementia subtypes (e.g., Alzheimer’s Disease, Lewy Body Dementia, Frontotemporal Dementia) in its prevalence, symptom profile, and timing of onset, making it challenging for clinicians to anticipate symptom progression and tailor treatments and care plans effectively. Research examining the brain’s structure and molecular studies evaluating biochemical markers support this, linking psychosis to distributed gray- and white-matter changes and to alterations in key blood biomarkers implicated in dementia. This variation suggests that the brain changes and molecular processes driving psychosis may differ across dementia subtypes, yet most research has focused on single diagnostic groups, limiting our understanding of which mechanisms are shared versus subtype specific. This study will be the first to systematically examine structural and molecular signatures of DRP across dementia subtypes. Leveraging the COMPASS-ND cohort of 700+ participants, a comprehensive Canadian dataset with clinical, imaging, and biomarker data, I will use MRI scans to assess changes in gray matter volume, cortical thickness, and white matter integrity in relation to psychosis symptoms, while integrating blood biomarkers to provide a more complete picture of the biological processes contributing to DRP. Comparing patterns across subtypes, this research aims to clarify the mechanisms underlying DRP, and support the development of more precise, individualized strategies for managing neuropsychiatric symptoms in dementia.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
573074
Name
Uthayakumar Harani
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Neurobiological Signatures of Psychosis Across Dementia Subtypes
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Alzheimer'S Disease; Blood Biomarkers; Dementia-Related Psychosis; Frontotemporal Dementia; Lewy Body Dementia; Magnetic Resonance Imaging; Multimodal Biomarker Integration; Neuroimaging Biomarkers; Neuropsychiatric Symptom Mechanisms; Parkinson'S Disease Dementia
Abstract
Dementia-related psychosis (DRP), which includes hallucinations and delusions, affects up to one-third of individuals with dementia and is associated with accelerated cognitive decline, earlier placement in care facilities, and substantial caregiver burden. DRP varies across dementia subtypes (e.g., Alzheimer’s Disease, Lewy Body Dementia, Frontotemporal Dementia) in its prevalence, symptom profile, and timing of onset, making it challenging for clinicians to anticipate symptom progression and tailor treatments and care plans effectively. Research examining the brain’s structure and molecular studies evaluating biochemical markers support this, linking psychosis to distributed gray- and white-matter changes and to alterations in key blood biomarkers implicated in dementia. This variation suggests that the brain changes and molecular processes driving psychosis may differ across dementia subtypes, yet most research has focused on single diagnostic groups, limiting our understanding of which mechanisms are shared versus subtype specific. This study will be the first to systematically examine structural and molecular signatures of DRP across dementia subtypes. Leveraging the COMPASS-ND cohort of 700+ participants, a comprehensive Canadian dataset with clinical, imaging, and biomarker data, I will use MRI scans to assess changes in gray matter volume, cortical thickness, and white matter integrity in relation to psychosis symptoms, while integrating blood biomarkers to provide a more complete picture of the biological processes contributing to DRP. Comparing patterns across subtypes, this research aims to clarify the mechanisms underlying DRP, and support the development of more precise, individualized strategies for managing neuropsychiatric symptoms in dementia.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Uthayakumar, Harani
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~